Healthcare Opportunities in Mexico

An Expert's View about Human Health Services in Mexico

Posted on: 4 Oct 2010

The value of the health sector in Mexico 2008 reached $13.48 billion USD, placing it as the second most important market in Latin America.

Sector briefing Healthcare Opportunities in Mexico Why Mexico? Mexico has a complex public health agenda. It is a developing country with a substantial population living below the poverty line. The population still faces the threat of diseases, such as infections and undernourishment. At the same time, however, it is facing health challenges specific to a developed country such as cancer, obesity, cardiopathies and diabetes. The National Development Plan 2007- 2012 endeavours to move towards more equal access to quality medical services through a functional integration of the public health institutions, under the leadership of the Health Business Monitor: ?The value of the Ministry. health sector in Mexico 2008 Mexico has been considered a high-growth reached $13.48 billion USD, placing pharmaceutical or ?pharmerging? market, it as the second most important now expected to add $1-5 billion USD to market in Latin America?? annual sales growth by 2013. Find general information on the Mexican market conditions on UKTI?s website. The Doing Business Guide for Mexico gives an overview of Mexico?s economy, business culture, potential opportunities and an introduction to other relevant issues. UK Trade & Investment Sector briefing: Healthcare Opportunities in Mexico Biotechnology Sector Opportunities The Mexican government identifies life sciences A number of key areas of specific interest have as one of the strategic industries for the been identified in the Mexican market: country and describes its subsectors as all burgeoning economic areas. According to Training in Geriatrics them, there are about 180 firms developing or working directly with biotechnology in Mexico, Recent continual population growth has of which 31% are involved in agriculture, 23% presented new health challenges for the in environmental applications, 18% in Mexican Ministry of Health. According to an healthcare and 18% in food. official census, in 2005 there were 8.2 million people over 60 years of age; by 2020 this Most of these areas have benefited from legal figure will increase to 15 million, and by 2040 reforms introduced in recent years, which one in four Mexicans will be in this age group. opened new opportunities across the board for foreign companies wishing to develop Although Mexico has created programmes and investment projects in Mexico or to increase infrastructure to meet the needs of the elderly, their presence in the country. it is also true that the geriatrics field as a speciality still fails to attract enough medical- Legal amendments in areas such as biofuels school graduates aspiring to become residents, and the biosafety of genetically modified whilst carers and specialised staff often do not organisms are described in the UKTI sector have the appropriate training. reports on Renewable Energy and Agriculture. Investment and supply of pharmaceuticals In 2004, the National Institute for Genomic Medicine (INMEGEN) was created, positioning According to ProMexico, the Government Mexico as a leader in Latin America. This year, institution in charge of coordinating actions to Carlos Slim, a Mexican business leader, attract foreign direct investment, there are announced the launch of a major 3-year more than 200 pharmaceutical companies research project in genomic medicine. The operating in Mexico and in 2007, the value of major goal of the project is to understand the the pharmaceutical industry?s output reached genomic basis of cancer, type 2 diabetes and $9.2 billion USD. kidney disease. Other factors contributing to market growth At the same time, there is a widely heard include the growth in hospital drug critique that there are not many 100% Mexican expenditure, a rise in drug consumption, as biotech companies, except in the generic ageing Mexicans spending power increases, pharmaceutical sector, where ProBiomed is prescription drug price increases, further referred to frequently. However, there are consolidation of the industry and a still infant plenty of less publicised examples, such as bioequivalent generic sector, as well as an GlobalBiotherapeutics which produces emerging biosimilars sector. innovative biotech products. Likewise, an area where Mexico has definitely carved out a niche In the next 5 years more than 5,000 patents of for itself is in the antivenoms market, where pharmaceutical products will expire Bioclon, a medium-sized company incorporated representing an opportunity for big companies by the pharmaceutical company Grupo Silanes, to develop the formula as a generic product. is a global market leader. Also, there are some good smaller companies working with These patents will also include, thus opening biocontrols for cultivation and several strong an important opportunity for biosimilar drugs. producers of veterinary products. In fact, in 2009 the General Health Act was amended to set the general framework for the Finally, in relation to intellectual property, regulation of biosimilars. The leading authority Mexico has a modern legal framework, offering (COFEPRIS) is now expected to issue the comprehensive and strong protection to secondary regulation completing such a biotechnological innovations, which includes a framework during 2010. linkage system for patents on medicines, as well as allowing patenting of living matter, UK Trade & Investment Sector briefing: Healthcare Opportunities in Mexico second uses for drugs and isolated genetic The development of Mexico?s healthcare material. market is largely through government health insurance. This is a major boost for the medical PPPs (Public Private Partnerships), device market and should attract multinational including training in PPP hospital players to Mexico in the future. management Additional strategic trade priorities As part of the government?s strategy to decentralise high specialisation health services, ? Telemedicine ? as a cross-sector the Ministry of Health has issued a Master Plan activity, bringing together engineering for Health. The first high speciality hospital and ICTs with applications for elderly built under the PPPs scheme started operations and ?special needs? population. in March 2007. The UK is held in very high ? Training, ICT for hospital and healthcare regard as a centre of excellence for PPP facilities management. consultancy. ? Innovative new drug development and/or R&D in diseases such as obesity, The PPP system has already been used to cancer, diabetes and NCS. modernise services, acquire new equipment ? Vaccines and/or treatments focusing on and comprehensive services in order to support preventing and healing emerging health units. infectious diseases such as TB and Dengue Fever, Hepatitis, Encephalitis Consultancy in institutional reform, caused by the West Nile Virus, etc. quality assessment and management, ? Partnering, licencing and distributorship. patient safety and medical ITs If you have any questions on the opportunities Since the National Strategy includes areas such above, contact the UKTI contacts named in this as processing homologation, accessibility, report. Business opportunities aimed efficiency, efficacy, quality guaranty, and specifically at UK companies are added daily to patients? security, there is a lot of space for UKTI?s website. These leads are sourced by our British guidance in these areas both on staff overseas in British Embassies, High technical and live support and intelligence. Commissions and Consulates, across all sectors and in over 100 markets. The great challenges that Mexico faces are: to address the fragmentation of information You can be alerted to business opportunities on systems, to include the private health sector in a regular basis by registering on the UKTI the national health statistics and, finally, the website. More on UKTI?s business opportunities automation of medical registries and service consolidation of data bases. Healthcare Promotion Prevention and promotion of health has an important role in Mexican Healthcare. In this sense, more resources need to be allocated to prevent diseases or alleviate the symptoms caused by chronic-degenerative diseases. Biomedical products and medical equipment Some of the high speciality equipment that Mexico holds within the public and private sector, are: tomography (175 public/185 private), lineal accelerators (30 public), litotriptors (93 public) and mammography equipment (346 public/273 private). UK Trade & Investment Sector briefing: Healthcare Opportunities in Mexico Major events and activities UKTI contacts Marcela Lopez Trade & Investment Officer British Embassy Mexico Tel: (0052 55) 1670 3243 Tourism Congress and Expo of Global Email: marcela.lopez@fco.gov.uk Medical www.ukti.gov.uk th August 27th to 26 , 2010 Puerto Vallarta, Mexico Paola Jimenez Trade & Investment Research Officer 6th International Congress of Micro British Embassy Mexico pigmentation Tel: (0052 55) 1670 3241 th th October 17 to 19 , 2010. Email: paola.jimenez@fco.gov.uk Ixtapa Zihuatanejo, Guerrero, México www.ukti.gov.uk 6th International Congress of urgencies British Embassy Mexico City and disasters infirmary Rio Lerma No. 71 th th October 28 to 30 , 2010 Col Cuauhtemoc Cancun, Quintana Roo, Mexico 06500 Mexico DF Tel: (0052 55) 1670 3200 XVIII Ibero Latin American Congress of Fax: (0052 55) 1670 3217 Dermatology www.embajadabritanica.com.mx th th November 10 to 14 , 2010 Cancun, Mexico Contact list Bioconnect Second International Mr. Roberto Galan Alema Networking Event President for the Healthcare Sector www.bio-connect.info National Chamber of the Manufacturing Industry info@bio-connect.info (CANACINTRA) th th October 7 -8 , 2010 Email: rgalanmx@yahoo.com Cuernavaca, Morelos, Mexico Mr. Rafael Gual Cosío Find full details of all Mexico Healthcare General Director events on the UKTI website. New export AMIIF (Mexican Association of Pharmaceutical events and business opportunities are added Research Industries) daily to the site and you can register to be Email: rgual@amiif.org.mx alerted to them on a daily, weekly or monthly basis Lic Carlos Abelleyra Cordero President UKTI?s Tradeshow Access Programme (TAP) National Chamber for the Pharmaceutical Industry provides grant support for eligible Small & (CANIFARMA) Medium Sized Enterprises (SME's) to attend Email: presidencia@canifarma.org.mx trade shows overseas. Find out more about UKTI support for attendance at overseas Dr Philippe Lamy events PAHO/WHO Representative in Mexico World Health Organisation / Panamerican Health Organisation Email: e-mail@mex.ops-oms.org Dr Manuel Ruiz de Chávez General Director Mexican Foundation for Health Email: mrch@funsalud.org.mx UK Trade & Investment Sector briefing: Healthcare Opportunities in Mexico Next steps ? How UKTI can help ? Arranging appointments British companies wishing to develop their ? Organise seminars or other events for business in the Mexican market are advised to you to meet contacts and promote your undertake as much market research and company in the Mexican market planning as possible in the UK. UKTI?s team in Mexico, with its wide local knowledge and This work is available via our Overseas Market experience, can provide a range of services to Introduction Service (OMIS) a chargeable British-based companies wishing to expand service which assists British-based companies their business in global markets. wishing to enter or expand their business in overseas markets. This can include: ? Provision of market information To find out more about commissioning this ? Validated lists of agents/distributors work, or accessing other UKTI services and ? Key market players or potential specialist advice, please visit the UKTI website customers in the Mexican market to find contact details for your local UKTI ? Establishment of interest of such office. contacts in working with you Whereas every effort has been made to ensure that the information given in this document is accurate, neither UK Trade & Investment nor its parent Departments (the Department for Business, Innovation & Skills, and the Foreign & Commonwealth Office), accept liability for any errors, omissions or misleading statements, and no warranty is given or responsibility accepted as to the standing of any individual, firm, company or other organisation mentioned. Published 2010 by UK Trade & Investment. Crown Copyright © UK Trade & Investment Sector briefing: Healthcare Opportunities in Mexico
Posted: 04 October 2010

See more from Human Health Services in Mexico

Expert Views    
Healthcare Opportunities in Mexico   By UK Trade & Investment
HEALTHCARE INDUSTRY   By U.S. Commercial Service Mexico
Latest News    
Sanitary Regulations for U.S. Medical Devices 2011   By U.S. Commercial Service